On May 1st the FDA issued "emergency use authorization" for intravenous use of Remdesivir in patients hospitalised with suspected/confirmed severe COVID-19 infection - defined as SpO2 ≤ 94%, need for O2, mech ventilation, or ECMO. https://t.co/XnBaclhPKm
Links:
US Food and Drug Administration allows emergency use of intravenous drug Remdes…
https://bit.ly/35sTOrA
May-04-2020
